Cosmetic treatment in patients with autoimmune connective tissue diseases : Best practices for patients with morphea/systemic sclerosis - 23/07/20
Abstract |
Morphea and systemic sclerosis are inflammatory, sclerosing disorders. Morphea primarily affects the dermis and subcutaneous fat, while systemic sclerosis typically involves the skin and internal organs. Functional impairment and cosmetic disfigurement are common in both diseases. Treatment options to mitigate disease progression remain limited. Both functional impairment and cosmetic deficits negatively impact quality of life and psychological well-being in this patient population. While the number of cosmetic procedures performed in the United States continues to rise each year, limited data exist regarding best practices for correcting aesthetic deficits caused by autoimmune conditions. There is scarce information to guide safety decisions regarding laser parameters, soft tissue augmentation, treatment intervals, and the concurrent use of immune-modifying or immune-suppressing medications. Given the fears of disease reactivation and exacerbation from postprocedural inflammation along with limited data, it is difficult for clinicians to provide evidence-based cosmetic treatment with realistic expectations with regard to short- and long-term outcomes. In the first article in this continuing medical education series, we attempt to address this practice gap.
Le texte complet de cet article est disponible en PDF.Key words : calcium hydroxylapatite, fat transfer, hyaluronic acid, injectables, intense pulsed light, mental health, morphea, poly-L-lactic acid, polymethylmethacrylate, pulsed dye laser, quality of life, systemic sclerosis
Abbreviations used : ECDS, HA, IPL, MDD, MHISS, PDL, PRS, QoL, SSc
Plan
Funding sources: None. |
|
Date of release: August 2020. |
|
Expiration date: August 2023. |
|
Conflicts of interest: None disclosed. |
Vol 83 - N° 2
P. 315-341 - août 2020 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?